CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...
GlobalData on MSN
CSA Medical submits application to FDA for RejuvenAir System
The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.
Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...
"2025 was a year that demonstrated Bambusa's execution-first culture," said Dr. Xu. "With multiple clinical programs advancing in parallel, we are entering 2026 positioned to deliver up to 10 clinical ...
A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is linked not only to smoking but also to factors such as obesity and systemic ...
A quasi-experimental study found anticipatory nursing in chronic obstructive pulmonary disease lowered anxiety and depression ...
Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel ...
We currently know that COPD, and specifically emphysema, don’t just happen alongside lung cancer; they increase a person’s ...
“Viruses can survive and circulate more easily in the cold, dry air and we also spend more time indoors which increases close ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results